Printer Friendly Version 

Investor FAQ

If you are interested in Isis Pharmaceuticals' investment details, you can find the answers to some frequently asked questions below.

1.Where are you located?
2.Can you provide a brief description of your Company?
3.When was the Company founded and when did it go public?
4.What is Isis' stock symbol and on what exchange is it traded?
5.How many shares are outstanding?
6.How can I purchase shares?
7.How can I get a copy of your annual report?
1.Where are you located?
 Isis Pharmaceuticals, Inc.
1896 Rutherford Road
Carlsbad, CA 92008-7208
(Carlsbad is approximately 35 miles north of downtown San Diego.)

2.Can you provide a brief description of your Company?
 Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 22 drugs in development. Isis’ drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis’ partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.

3.When was the Company founded and when did it go public?
 Isis Pharmaceuticals, Inc. was founded in 1989. Isis conducted its initial public offering two years later in 1991.

4.What is Isis' stock symbol and on what exchange is it traded?
 Isis is traded on the NASDAQ stock exchange under the symbol ISIS. Please note that prior to February 21, 2002 our symbol was ISIP.

5.How many shares are outstanding?
 The number of shares of voting common stock outstanding as of February 22, 2010 was 99,063,964.

6.How can I purchase shares?
 To purchase Isis stock you may use the broker of your choice. Isis does not offer a direct stock purchase plan.

7.How can I get a copy of your annual report?
 To view a PDF file of the annual reports from 2007-2009 click here. If you would like to receive a hard copy of any of Isis' annual reports, please click here. Please note that if you are requesting that we send the annual report to an address outside of the U.S. (including Canada and Mexico) you must include your telephone number. The US Postal Service requires a phone number for shipments out of the U.S.

Online Investor Kit

Quickly download files right from our Investor Relations Web site.

Learn More

Financial Tearsheet

Download a brief overview of Isis.

Learn More

News Feeds

Get the latest.

Subscribe

Receive Isis alerts in your email.

Sign Up